Temperature sensitivity of cyclic AMP production and catecholamine-induced refractoriness in a rat astrocytoma cell line
- 1 November 1978
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 75 (11) , 5520-5524
- https://doi.org/10.1073/pnas.75.11.5520
Abstract
Intracellular cyclic[c]AMP was increased more than 100-fold when rat C6-2B astrocytoma cells were treated with isoproterenol in the cold (4.degree. C). When the cells were treated with the phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine, and isoproterenol, cAMP levels rose more than 150-fold. The levels achieved compared favorably with the 250-fold increase in cAMP produced by (-)isoproterenol at 37.degree. C. (-)Isoproterenol at 5 nM stimulated half-maximal cAMP production at 4.degree. C and at 37.degree. C and was blocked by (-)propranolol at both temperatures. The concentrations of cAMP attained by these cells after (-)isoproterenol stimulation in the cold may be accounted for, in part, by alterations in the efflux of the nucleotide from the cells since extracellular cAMP, an indicator of cAMP efflux, was found to be dramatically reduced in the cold. The cells, when exposed to (-)isoproterenol for up to 6 h at low temperature, maintained normal responsiveness to this agent when rechallenged at 4.degree. or 37.degree. C. They did not display agonist-induced refractoriness during that period of exposure at 4.degree. C, although refractoriness is always seen within 90 min at 37.degree. C. Refractoriness, once established by (-)isoproterenol treatment at 37.degree. C, was not reversed by exposure of the cells to cold. These data suggest that the development of catecholamine refractoriness requires a temperature-sensitive step that lies distal to the hormone-receptor interaction and cAMP generation.This publication has 20 references indexed in Scilit:
- Regulation of receptor concentration by homologous hormone. Effect of human growth hormone on its receptor in IM-9 lymphocytes.Journal of Biological Chemistry, 1976
- The lipid environment of the glucagon receptor regulates adenylate cyclase activityBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976
- Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.Journal of Clinical Investigation, 1976
- Fatty acids as modulators of membrane functions: catecholamine-activated adenylate cyclase of the turkey erythrocyte.Proceedings of the National Academy of Sciences, 1975
- Human synoviocytes: activation and desensitization by prostaglandins and 1-epinephrine.Proceedings of the National Academy of Sciences, 1975
- Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro.Journal of Biological Chemistry, 1975
- Regulation of adenosine 3' :5'-monophosphate efflux from rat glioma cells in culture*Journal of Biological Chemistry, 1975
- Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.1975
- PGE1-mediated cyclic AMP refractoriness: effects of cycloheximide and indomethacin.1975
- Reversal of Catecholamine Refractoriness by Inhibitors of RNA and Protein SynthesisScience, 1974